Biology of ductal carcinoma in situ classification based on biologic potential

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 29, Issue 3, 2006, Pages 305-310

  Tsikitis, Vassiliki L ^a   Chung, Maureen A ^a,b  

^a BROWN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Breast; Classification schemes; Duct carcinoma in situ

Indexed keywords

BREAST DUCT; BREAST EPITHELIUM; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INCIDENCE; CANCER INVASION; CARCINOMA IN SITU; CELL PROLIFERATION; DISEASE CLASSIFICATION; EPITHELIUM CELL; HUMAN; INTRADUCTAL CARCINOMA; PRACTICE GUIDELINE; REVIEW; BREAST TUMOR; CANCER STAGING; DISEASE COURSE; FEMALE; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS;

TUMOR MARKER;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE PROGRESSION; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33744978091     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000198740.33617.2f     Document Type: Review

References (39)

1. Ernster VL, Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr. 1997;22:151-156.
2. Subramanian B, Axelrod DE. Progression of heterogeneous breast tumors. J Theor Biol. 2001;210:107-119.
3. Bellamy CO, McDonald C, Salter DM, et al. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol. 1993;24:16-23.
4. Lagios MD, Margolin FR, Westdahl PR, et al. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 1989;63:618-624.
5. Scott MA, Lagios MD, Axelsson K, et al. Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis. Hum Pathol. 1997;28:967-973.
6. Poller DN, Silverstein MJ, Galea M, et al. Ideas in pathology: ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol. 1994;7:257-262.
7. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol. 1994;11:167-180.
8. Lagios MD. Heterogeneity of duct carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation. Cancer Lett. 1995;90:97-102.
9. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet. 1995;345:1154-1157.
10. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77:2267-2274.
11. Consensus Conference on the Classification of Ductal Carcinoma in situ. The Consensus Conference Committee. Cancer. 1997;80:1798-1802.
12. Schwartz GF, Solin LJ, Olivotto IA, et al. Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Cancer. 2000;88:946-954.
13. Rudas M, Neumayer R. p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Eur J Cancer. 1997;33:39-44.
14. Rajan PB, Scott DJ, Perry RH, et al. p53 Protein expression in ductal carcinoma in situ (DCIS) of the breast. Breast Cancer Res Treat. 1997;42:283-290.
15. Thor AD, Moore DH II, Edgerton SM, et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst. 1992;84:845-855.
16. Tsuda H, Iwaya K, Fukutomi T, et al. p53 Mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade. Jpn J Cancer Res. 1993;84:394-401.
17. Bartek J, Bartkova J, Vojtesek B, et al. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int J Cancer. 1990;46:839-844.
18. Leal CB, Schmitt FC, Bento MJ, et al. Ductal carcinoma in situ of the breast: histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein. Cancer. 1995;75:2123-2131.
19. Claus EB, Chu P, Howe CL, et al. Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors. Exp Mol Pathol. 2001;70:303-316.
20. Mack L, Kerkvliet N, Doig G, et al. Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67. Hum Pathol. 1997;28:974-979.
21. Moore E, Magee H, Coyne J, et al. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast: comparative genomic hybridization study of pure high-grade DCIS. J Pathol. 1999;187:403-409.
22. Zafrani B, Leroyer A, Fourquet A, et al. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification: a study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. Semin Diagn Pathol. 1994;11:208-214.
23. Ghali VS, Liau S, Teplitz C, et al. A comparative study of DNA ploidy in 115 fresh-frozen breast carcinomas by image analysis versus flow cytometry. Cancer. 1992;70:2668-2672.
24. Bobrow LG, Happerfield LC, Gregory WM, et al. The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagn Pathol. 1994;11:199-207.
25. Boland GP, Butt IS, Prasad R, et al. COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer. 2004;90:423-429.
26. Sanders ME, Schuyler PA, Dupont WD, et al. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 2005;103:2481-2484.
27. Schnitt S. Columnar cell lesions of the breast (case reviews). Pathol Case Rev. 2003;8:201-210.
28. Page DL, Simpson JF, Jensen RA, et al. Atypical ductal hyperplasia on core biopsy: is there a subset of atypical ductal hyperplasia lesions on core biopsy that does not require local excision? Pathol Case Rev. 2003;8:245-248.
29. Nasser SM. Columnar cell lesions: current classification and controversies. Semin Diagn Pathol. 2004;21:18-24.
30. Fraser J, Raza S, Chorny K. Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol. 1998;22:1521-1527.
31. Eusebi V, Feudale E, Foschini MP, et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol. 1994;11:223-235.
32. Moinfar F, Man YG, Bratthauer GL, et al. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium. Cancer. 2000;88:2072-2081.
33. Kusama R, Fujimori M, Matsuyama I, et al. Clinicopathological characteristics of atypical cystic duct (ACD) of the breast: assessment of ACD as a precancerous lesion. Pathol Int. 2000;50:793-800.
34. Simooka H, Oyama T, Sano T, et al. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis. Pathol Int. 2004;54(8):595-602..
35. Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A. 2003;100:5974-5979.
36. O'Neill PA, Shaaban AM, West CR, et al. Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27. Br J Cancer. 2004;90:182-188.
37. Roylance R, Gorman P, Harris W, et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 1999;59:1433-1436.
38. Gupta SK, Douglas-Jones AG, Fenn N, et al. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ). Cancer. 1997;80:1740-1745.
39. Rosenberg CL, Larson PS, Romo JD, et al. Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer. Hum Pathol. 1997;28:214-219.